Mankind Pharma Limited has acquired Bharat Serums and Vaccines Limited from Advent International in a deal valued at $1.6 billion (approximately Rs 13,600 crore).
Khaitan & Co advised Advent International and AZB & Partners advised Mankind Pharma on the sale of Bharat Serums and Vaccines Limited for approx. USD 1.6 billion to MANKIND PHARMA LTD.
Mankind Pharma Ltd has announced it will acquire a 100% stake in Bharat Serums and Vaccines Ltd (BSV) from the private equity firm Advent International, with the deal valued at approximately ₹13,630 crore, subject to final adjustments.
Khaitan’s deal team included Aakash Choubey (Partner), Aashutosh Sampat (Partner), Sameer Sah (Partner), Anshuman Mozumdar (Partner), Ayush Sinha (Senior Associate), Sagarika Chandel (Senior Associate), Aditi Halder (Associate), Ankush Unni (Associate), Amogh Pareek (Associate), Abhishek Singh (Associate) and Arun Kumar (Associate).
AZB & Partners advised Mankind Pharma and the team was led by Senior Partner Vaidyanathan Iyer, with Partner Sneha Nagvekar, Senior Associates Sana Nagar and Karun Khangiani, and Associates Shivam Gupta and Akanksha Khandelwal. Supported by Partner Nikunj Maheshwari, Counsel Nitika Jain, and Associates Piyush Tiwari and Nikita Bhosle on financing, Partner Bharat V Budholia, Senior Associate Vayshnavi Ganesh, and Associates Shaurya Kumar and Ileina Srivastav on competition law, and Partners Nandan Pendsey and Ajay Singh Solanki, Senior Associates Veeral Vakharia, Rashmee Kumar, Rhea Ghanshani, Sayantani Saha, and Associates Rohan Puskar, Jay Singhee, Thangam Chandy, Tarini Mehtani, and Rishav Sen on due diligence.
This acquisition is a major strategic move for Mankind Pharma, enhancing its position as a leader in the Indian market for women’s health and fertility drugs. It will also provide access to other high-entry barrier products in critical care, backed by established complex R&D technology platforms, according to the company’s statement.
BSV offers a comprehensive portfolio in Women’s Health, covering all stages from fertility through to post-pregnancy.
Share your news, articles, deals, columns, or press releases with us! Click the link to submit and join our platform today.
